ZeaKal raises $5.3M Series B

What does Zeakal do?

Zeakal, is biotechnology startup which is focused on improving agricultural productivity. The company is developing technology for vastly increasing the yield and oil content of multiple crops. It has developed from the incubation pipeline of Kapyon Ventures. The company’s technology is being developed for increasing the yield and the oil content of many crops. Its HME technology has been shown to increase the oil and yield content of multiple crops, which would meaningfully impact the demand for biomass across feed, food and fuels.

How much Zekal was funded?

Zeakalraised$5.3M in Series B on February 17, 2016 from Middleland Capital and Finistere Ventures.

Previous funding

• $3.8M in Series A on March 26, 2013 from  Kapyon Ventures, Two Oceans, Finistere Ventures and Missouri Soybean.

What is next for zeakal?

The company has raised a total of $9.1M to date. It has acquired an industrial biotech company called Algenetix, which develops renewable materials and energies from the plant based sources. The latest round of funding was lead by many leading family office investors and with this funding the company has plans to expand its PhotoSeed product development pipeline and for bringing its lead soybean production into field trails this coming May.

More about Zeakal

Zeakal was founded in 2010. It has its headquarters in San Diego, CA. This is a revolutionary tech play in plant science. The company is adamant that the world requires better biology for coping with the increasing environmental pressures. The company has an out of the box technology approach which increases photosynthetic efficiency and carbon fixation in plants for addressing the shortcoming of the previous strategies in science. Its trademark PhotoSeed technology is a next gen biology which address the pressing challenges. This technology can harvest more sunlight and fix more carbon dioxide and that too with less water.